Shanghai Lanfu Chemical Technology Co., Ltd. – Trademark Portfolio

Entity Type: 99

Shanghai Lanfu Chemical Technology Co., Ltd. holds 1 U.S. trademark filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 1 (Chemicals) — 1 filings in this category. Currently, 1 trademark is registered. Notable registered marks include LANFU. The owner is based in Shanghai.

Room 12905, Building 2

No.1 Haikun Road, Fengxian District

Shanghai 201400 , CN

1 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

LANFU
LANFU
Registered 2024

Trademark Classifications

Shanghai Lanfu Chemical Technology Co., Ltd.'s trademark portfolio spans 1 Nice Classification class, reflecting the scope of goods and services protected under their brand portfolio.

1
Chemicals (1 filing)

Chemical products for industry, science, photography, agriculture, horticulture and forestry

Frequently Asked Questions

How many trademarks does Shanghai Lanfu Chemical Technology Co., Ltd. have?

Shanghai Lanfu Chemical Technology Co., Ltd. has 1 U.S. trademark filed with the USPTO. Of these, 1 registered.

What trademark classes does Shanghai Lanfu Chemical Technology Co., Ltd. file in?

Shanghai Lanfu Chemical Technology Co., Ltd. files trademarks across 1 Nice Classification class. The most active classes are Class 1 (Chemicals). Class 1 covers chemical products for industry, science, photography, agriculture, horticulture and forestry.

What are Shanghai Lanfu Chemical Technology Co., Ltd.'s most well-known trademarks?

Shanghai Lanfu Chemical Technology Co., Ltd.'s registered trademark portfolio includes well-known marks such as LANFU. These are among 1 currently registered trademark in the portfolio.

What is Shanghai Lanfu Chemical Technology Co., Ltd.'s trademark registration success rate?

Shanghai Lanfu Chemical Technology Co., Ltd. has a 100% trademark registration rate, with 1 out of 1 resolved applications resulting in successful registration. Currently, 0 applications are pending review.